Nektar Therapeutics (NKTR) slipped -8.82% or -4.09 to $42.26. It is near to 3.97 million shares traded, which is 222.52% compare to the average total volume 1.79 million. The market cap of NKTR is $7.31 billion. The year to date change is 26.62%. The 52 week price range is from $29.22 to $111.36. Price of NKTR have changed 5.94% during last week. It have changed 13.02% over last month, 25.30% over last 3 months, -21.85% over last 6 months and -41.11% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NKTR is 39.44. It is -6.67% below current price. The 200-day Moving Averages for NKTR is 53.18. It is 25.84% above current price. The 52-week High is 111.36. It is 163.51% from the current price. The 52-week Low is 29.22. It is -30.86% from current price.
There are some statistics of NKTR. It is has market cap $7.31 billion. The share outstanding is 173.09 million. The average volume is 1.79 million. The percent of top 15 Institution holding is 161.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NKTR is 79.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NKTR is 52.68%.